CLOVClover Health Investments, Corp.
$4.81+39% 1Y
$4.81
$1.7052 weeks$5.41
What has happened
CLOV in its own filings
CLOV's filing record carries 3 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
174
Events found in the filings · across 708 filings · the record starts in 2020
- Hard flags
- 3
Hard flags
- Most recent filing
- Nov 4, 2026
Most recent filing · Form 8-K
- Record starts
- Feb 20, 2020
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filinga quarter after the last one
- expected around Feb 3, 2027
- Restatement admitted (non-reliance)historical
- 2021-05-17
- Change in certifying accountanthistorical
- 2021-01-12
- Delisting notice / listing-rule failure3 occurrences
- 2024-04-05
- Security removed from listing or deregistered2 occurrences · usually a matured note or preferred class, not the common shares
- 2021-08-23
- Material impairmentpast_3y
- 2023-12-01
- SEC comment-letter activity28 occurrences
- 2022-12-15
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Earnings release
On November 2, 2026, the Board of Directors of the Company appointed Joseph Clay Thornton, age 37, the Company’s Interim Chief Financial Officer and principal financial officer, to serve as the Company’s Chief Financial Officer on a permanent basis, and appointed Joseph Frank Oldakowski, age 44, the Company’s Vice …
Form 8-K on sec.gov ↗ - Regulation FD disclosure
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027.
The press release on sec.gov ↗ - Director or officer change
On September 22, 2026, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Senator Robert G. Torricelli to serve as a Class I director of the Board and Dr. Brian J. Miller, M.D., M.B.A., M.P.H. to serve as a Class III director of the Board.
Form 8-K/A on sec.gov ↗
Earlier reports (6)›
- Director or officer change
On September 22, 2026, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Senator Robert G. Torricelli to serve as a Class I director of the Board and Dr. Brian J. Miller, M.D., M.B.A., M.P.H. to serve as a Class III director of the Board.
Form 8-K on sec.gov ↗ - Other event
On July 4, 2026, Clover Health Investments, Corp. (the “Company”) became aware of anomalous login activity on certain of its information systems.
Form 8-K on sec.gov ↗ - Other event
As previously disclosed, on June 9, 2026, the Centers for Medicare & Medicaid Services ("CMS") informed Clover Health Investments, Corp. (the "Company") that, consistent with a court judgment in Clover Insurance Co. V. HHS, Civ.
Form 8-K on sec.gov ↗ - Director or officer change
On June 15, 2026, Brady Priest notified Clover Health Investments, Corp. (the “Company”) of his decision to step down from his position as Chief Executive Officer of Clover Care Services, the Company’s home-care business, effective as of July 3, 2026.
Form 8-K on sec.gov ↗ - Other event
On May 29, 2026, the United States District Court for the Southern District of Georgia entered final judgment in Clover Insurance Co. v.
Form 8-K on sec.gov ↗
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Healthcare
The closest names by size in the same sector